Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for G-CSF Biosimilars in US$ by the following Product Segments: Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating FactorCompany profiles are primarily based on public domain information including company Merck & Co.NovartisJohnson & JohnsonGlaxoSmithKlinePfizerAbbVieBayerJohnson & JohnsonAmgenSanofiMerck & CoAstraZeneca
This report offers an overview of the market trends, drivers, and barriers with respect to the USA G-CSF Biosimilars market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA G-CSF Biosimilars market. Detailed analysis of key players, along with key growth strategies adopted by G-CSF Biosimilars industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sanofi
Merck & Co
AstraZeneca
Roche
Novartis
Gilead Science
GlaxoSmithKline
Pfizer
AbbVie
Bayer
Johnson & Johnson
Amgen
By Type:
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
By End-User:
Blood Disorders
Oncology Diseases
Chronic And Autoimmune Diseases
Growth Hormone Deficiencies
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of G-CSF Biosimilars Market
-
1.3 Market Segment by Type
-
1.3.1 USA G-CSF Biosimilars Market Size and Growth Rate of Human Growth Hormone from 2016 to 2027
-
1.3.2 USA G-CSF Biosimilars Market Size and Growth Rate of Erythropoietin from 2016 to 2027
-
1.3.3 USA G-CSF Biosimilars Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027
-
1.3.4 USA G-CSF Biosimilars Market Size and Growth Rate of Insulin from 2016 to 2027
-
1.3.5 USA G-CSF Biosimilars Market Size and Growth Rate of Interferon from 2016 to 2027
-
1.3.6 USA G-CSF Biosimilars Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA G-CSF Biosimilars Market Size and Growth Rate of Blood Disorders from 2016 to 2027
-
1.4.2 USA G-CSF Biosimilars Market Size and Growth Rate of Oncology Diseases from 2016 to 2027
-
1.4.3 USA G-CSF Biosimilars Market Size and Growth Rate of Chronic And Autoimmune Diseases from 2016 to 2027
-
1.4.4 USA G-CSF Biosimilars Market Size and Growth Rate of Growth Hormone Deficiencies from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA G-CSF Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA G-CSF Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA G-CSF Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA G-CSF Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of G-CSF Biosimilars Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of G-CSF Biosimilars by Major Types
-
3.4.1 Market Size and Growth Rate of Human Growth Hormone
-
3.4.2 Market Size and Growth Rate of Erythropoietin
-
3.4.3 Market Size and Growth Rate of Monoclonal Antibodies
-
3.4.4 Market Size and Growth Rate of Insulin
-
3.4.5 Market Size and Growth Rate of Interferon
-
3.4.6 Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor
4 Segmentation of G-CSF Biosimilars Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of G-CSF Biosimilars by Major End-Users
-
4.4.1 Market Size and Growth Rate of G-CSF Biosimilars in Blood Disorders
-
4.4.2 Market Size and Growth Rate of G-CSF Biosimilars in Oncology Diseases
-
4.4.3 Market Size and Growth Rate of G-CSF Biosimilars in Chronic And Autoimmune Diseases
-
4.4.4 Market Size and Growth Rate of G-CSF Biosimilars in Growth Hormone Deficiencies
5 Market Analysis by Regions
-
5.1 USA G-CSF Biosimilars Production Analysis by Regions
-
5.2 USA G-CSF Biosimilars Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA G-CSF Biosimilars Landscape Analysis
-
6.1 West USA G-CSF Biosimilars Landscape Analysis by Major Types
-
6.2 West USA G-CSF Biosimilars Landscape Analysis by Major End-Users
7 South USA G-CSF Biosimilars Landscape Analysis
-
7.1 South USA G-CSF Biosimilars Landscape Analysis by Major Types
-
7.2 South USA G-CSF Biosimilars Landscape Analysis by Major End-Users
8 Middle West USA G-CSF Biosimilars Landscape Analysis
-
8.1 Middle West USA G-CSF Biosimilars Landscape Analysis by Major Types
-
8.2 Middle West USA G-CSF Biosimilars Landscape Analysis by Major End-Users
9 Northeast USA G-CSF Biosimilars Landscape Analysis
-
9.1 Northeast USA G-CSF Biosimilars Landscape Analysis by Major Types
-
9.2 Northeast USA G-CSF Biosimilars Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Sanofi
-
10.1.1 Sanofi Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Merck & Co
-
10.2.1 Merck & Co Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 AstraZeneca
-
10.3.1 AstraZeneca Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Roche
-
10.4.1 Roche Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Novartis
-
10.5.1 Novartis Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Gilead Science
-
10.6.1 Gilead Science Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 GlaxoSmithKline
-
10.7.1 GlaxoSmithKline Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Pfizer
-
10.8.1 Pfizer Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 AbbVie
-
10.9.1 AbbVie Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Bayer
-
10.10.1 Bayer Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Johnson & Johnson
-
10.11.1 Johnson & Johnson Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Amgen
-
10.12.1 Amgen Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA G-CSF Biosimilars Market Size and Growth Rate of Human Growth Hormone from 2016 to 2027
-
Figure USA G-CSF Biosimilars Market Size and Growth Rate of Erythropoietin from 2016 to 2027
-
Figure USA G-CSF Biosimilars Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027
-
Figure USA G-CSF Biosimilars Market Size and Growth Rate of Insulin from 2016 to 2027
-
Figure USA G-CSF Biosimilars Market Size and Growth Rate of Interferon from 2016 to 2027
-
Figure USA G-CSF Biosimilars Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA G-CSF Biosimilars Market Size and Growth Rate of Blood Disorders from 2016 to 2027
-
Figure USA G-CSF Biosimilars Market Size and Growth Rate of Oncology Diseases from 2016 to 2027
-
Figure USA G-CSF Biosimilars Market Size and Growth Rate of Chronic And Autoimmune Diseases from 2016 to 2027
-
Figure USA G-CSF Biosimilars Market Size and Growth Rate of Growth Hormone Deficiencies from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA G-CSF Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA G-CSF Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA G-CSF Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA G-CSF Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of G-CSF Biosimilars Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of G-CSF Biosimilars
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of G-CSF Biosimilars by Different Types from 2016 to 2027
-
Table Consumption Share of G-CSF Biosimilars by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Human Growth Hormone
-
Figure Market Size and Growth Rate of Erythropoietin
-
Figure Market Size and Growth Rate of Monoclonal Antibodies
-
Figure Market Size and Growth Rate of Insulin
-
Figure Market Size and Growth Rate of Interferon
-
Figure Market Size and Growth Rate of Granulocyte-Colony Stimulating Factor
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of G-CSF Biosimilars by Different End-Users from 2016 to 2027
-
Table Consumption Share of G-CSF Biosimilars by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Blood Disorders
-
Figure Market Size and Growth Rate of Oncology Diseases
-
Figure Market Size and Growth Rate of Chronic And Autoimmune Diseases
-
Figure Market Size and Growth Rate of Growth Hormone Deficiencies
-
Table USA G-CSF Biosimilars Production by Regions
-
Table USA G-CSF Biosimilars Production Share by Regions
-
Figure USA G-CSF Biosimilars Production Share by Regions in 2016
-
Figure USA G-CSF Biosimilars Production Share by Regions in 2021
-
Figure USA G-CSF Biosimilars Production Share by Regions in 2027
-
Table USA G-CSF Biosimilars Consumption by Regions
-
Table USA G-CSF Biosimilars Consumption Share by Regions
-
Figure USA G-CSF Biosimilars Consumption Share by Regions in 2016
-
Figure USA G-CSF Biosimilars Consumption Share by Regions in 2021
-
Figure USA G-CSF Biosimilars Consumption Share by Regions in 2027
-
Table West USA G-CSF Biosimilars Consumption by Types from 2016 to 2027
-
Table West USA G-CSF Biosimilars Consumption Share by Types from 2016 to 2027
-
Figure West USA G-CSF Biosimilars Consumption Share by Types in 2016
-
Figure West USA G-CSF Biosimilars Consumption Share by Types in 2021
-
Figure West USA G-CSF Biosimilars Consumption Share by Types in 2027
-
Table West USA G-CSF Biosimilars Consumption by End-Users from 2016 to 2027
-
Table West USA G-CSF Biosimilars Consumption Share by End-Users from 2016 to 2027
-
Figure West USA G-CSF Biosimilars Consumption Share by End-Users in 2016
-
Figure West USA G-CSF Biosimilars Consumption Share by End-Users in 2021
-
Figure West USA G-CSF Biosimilars Consumption Share by End-Users in 2027
-
Table South USA G-CSF Biosimilars Consumption by Types from 2016 to 2027
-
Table South USA G-CSF Biosimilars Consumption Share by Types from 2016 to 2027
-
Figure South USA G-CSF Biosimilars Consumption Share by Types in 2016
-
Figure South USA G-CSF Biosimilars Consumption Share by Types in 2021
-
Figure South USA G-CSF Biosimilars Consumption Share by Types in 2027
-
Table South USA G-CSF Biosimilars Consumption by End-Users from 2016 to 2027
-
Table South USA G-CSF Biosimilars Consumption Share by End-Users from 2016 to 2027
-
Figure South USA G-CSF Biosimilars Consumption Share by End-Users in 2016
-
Figure South USA G-CSF Biosimilars Consumption Share by End-Users in 2021
-
Figure South USA G-CSF Biosimilars Consumption Share by End-Users in 2027
-
Table Middle West USA G-CSF Biosimilars Consumption by Types from 2016 to 2027
-
Table Middle West USA G-CSF Biosimilars Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA G-CSF Biosimilars Consumption Share by Types in 2016
-
Figure Middle West USA G-CSF Biosimilars Consumption Share by Types in 2021
-
Figure Middle West USA G-CSF Biosimilars Consumption Share by Types in 2027
-
Table Middle West USA G-CSF Biosimilars Consumption by End-Users from 2016 to 2027
-
Table Middle West USA G-CSF Biosimilars Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA G-CSF Biosimilars Consumption Share by End-Users in 2016
-
Figure Middle West USA G-CSF Biosimilars Consumption Share by End-Users in 2021
-
Figure Middle West USA G-CSF Biosimilars Consumption Share by End-Users in 2027
-
Table Northeast USA G-CSF Biosimilars Consumption by Types from 2016 to 2027
-
Table Northeast USA G-CSF Biosimilars Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA G-CSF Biosimilars Consumption Share by Types in 2016
-
Figure Northeast USA G-CSF Biosimilars Consumption Share by Types in 2021
-
Figure Northeast USA G-CSF Biosimilars Consumption Share by Types in 2027
-
Table Northeast USA G-CSF Biosimilars Consumption by End-Users from 2016 to 2027
-
Table Northeast USA G-CSF Biosimilars Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA G-CSF Biosimilars Consumption Share by End-Users in 2016
-
Figure Northeast USA G-CSF Biosimilars Consumption Share by End-Users in 2021
-
Figure Northeast USA G-CSF Biosimilars Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Merck & Co
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co
-
Figure Sales and Growth Rate Analysis of Merck & Co
-
Figure Revenue and Market Share Analysis of Merck & Co
-
Table Product and Service Introduction of Merck & Co
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Gilead Science
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Science
-
Figure Sales and Growth Rate Analysis of Gilead Science
-
Figure Revenue and Market Share Analysis of Gilead Science
-
Table Product and Service Introduction of Gilead Science
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
